BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 29361917)

  • 21. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
    Medrek C; Pontén F; Jirström K; Leandersson K
    BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma.
    Lisi L; Ciotti GM; Braun D; Kalinin S; Currò D; Dello Russo C; Coli A; Mangiola A; Anile C; Feinstein DL; Navarra P
    Neurosci Lett; 2017 Apr; 645():106-112. PubMed ID: 28259657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma.
    Cornelissen R; Lievense LA; Maat AP; Hendriks RW; Hoogsteden HC; Bogers AJ; Hegmans JP; Aerts JG
    PLoS One; 2014; 9(9):e106742. PubMed ID: 25192022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Impact of CD163+ Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer.
    Miura T; Yoshizawa T; Hirai H; Seino H; Morohashi S; Wu Y; Wakiya T; Kimura N; Kudo D; Ishido K; Toyoki Y; Kijima H; Hakamada K
    Anticancer Res; 2017 Jan; 37(1):183-190. PubMed ID: 28011489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. M2-macrophage infiltration and macrophage traits of tumor cells in urinary bladder cancer.
    Aljabery F; Olsson H; Gimm O; Jahnson S; Shabo I
    Urol Oncol; 2018 Apr; 36(4):159.e19-159.e26. PubMed ID: 29288002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles.
    Herwig MC; Bergstrom C; Wells JR; Höller T; Grossniklaus HE
    Exp Eye Res; 2013 Feb; 107():52-8. PubMed ID: 23206928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
    Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
    Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of M2-macrophages in uveal melanoma and relation with survival.
    Bronkhorst IH; Ly LV; Jordanova ES; Vrolijk J; Versluis M; Luyten GP; Jager MJ
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):643-50. PubMed ID: 20811059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS/PI3K signaling-dependent various cytokine production to promote NSCLC growth.
    Zhang J; Li H; Wu Q; Chen Y; Deng Y; Yang Z; Zhang L; Liu B
    Redox Biol; 2019 Apr; 22():101116. PubMed ID: 30769285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer.
    Miotto D; Lo Cascio N; Stendardo M; Querzoli P; Pedriali M; De Rosa E; Fabbri LM; Mapp CE; Boschetto P
    Lung Cancer; 2010 Sep; 69(3):355-60. PubMed ID: 20089329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages.
    Vieira T; Antoine M; Hamard C; Fallet V; Duruisseaux M; Rabbe N; Rodenas A; Cadranel J; Wislez M
    Lung Cancer; 2016 Aug; 98():51-58. PubMed ID: 27393506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prognostic Significance of pSTAT1 and CD163 Expressions in Surgically Resected Stage 1 Pulmonary Squamous Cell Carcinomas.
    Lin MW; Yang CY; Kuo SW; Wu CT; Chang YL; Yang PC
    Ann Surg Oncol; 2016 Sep; 23(9):3071-81. PubMed ID: 27150441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myeloid-Derived Suppressor Cells and CD68
    Lv M; Zhuang X; Shao S; Li X; Cheng Y; Wu D; Wang X; Qiao T
    J Immunol Res; 2022; 2022():3621496. PubMed ID: 35928634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution and presumed proliferation of macrophages in inflammatory diseases of the ocular adnexae.
    Herwig MC; Holz FG; Loeffler KU
    Curr Eye Res; 2015 May; 40(6):604-10. PubMed ID: 25111002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.
    Hu JM; Liu K; Liu JH; Jiang XL; Wang XL; Chen YZ; Li SG; Zou H; Pang LJ; Liu CX; Cui XB; Yang L; Zhao J; Shen XH; Jiang JF; Liang WH; Yuan XL; Li F
    Oncotarget; 2017 Mar; 8(13):21526-21538. PubMed ID: 28423526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis.
    Mei J; Xiao Z; Guo C; Pu Q; Ma L; Liu C; Lin F; Liao H; You Z; Liu L
    Oncotarget; 2016 Jun; 7(23):34217-28. PubMed ID: 27144518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer.
    Chung FT; Lee KY; Wang CW; Heh CC; Chan YF; Chen HW; Kuo CH; Feng PH; Lin TY; Wang CH; Chou CL; Chen HC; Lin SM; Kuo HP
    Int J Cancer; 2012 Aug; 131(3):E227-35. PubMed ID: 22174092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.
    Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y
    Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly.
    Poles WA; Nishi EE; de Oliveira MB; Eugênio AIP; de Andrade TA; Campos AHFM; de Campos RR; Vassallo J; Alves AC; Scapulatempo Neto C; Paes RAP; Landman G; Zerbini MCN; Colleoni GWB
    Cancer Immunol Immunother; 2019 Feb; 68(2):269-282. PubMed ID: 30430204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.
    Ayari C; LaRue H; Hovington H; Decobert M; Harel F; Bergeron A; Têtu B; Lacombe L; Fradet Y
    Eur Urol; 2009 Jun; 55(6):1386-95. PubMed ID: 19193487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.